Does TYSABRI Cause Neoplasm malignant? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Neoplasm malignant have been filed in association with TYSABRI. This represents 0.3% of all adverse event reports for TYSABRI.
21
Reports of Neoplasm malignant with TYSABRI
0.3%
of all TYSABRI reports
3
Deaths
5
Hospitalizations
How Dangerous Is Neoplasm malignant From TYSABRI?
Of the 21 reports, 3 (14.3%) resulted in death, 5 (23.8%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TYSABRI. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does TYSABRI Cause?
Multiple sclerosis relapse (811)
Fatigue (759)
Malaise (523)
Gait disturbance (445)
Multiple sclerosis (443)
Memory impairment (422)
Headache (368)
Drug ineffective (329)
Asthenia (328)
Fall (324)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which TYSABRI Alternatives Have Lower Neoplasm malignant Risk?
TYSABRI vs TYVASO
TYSABRI vs UBIDECARENONE
TYSABRI vs UBLITUXIMAB
TYSABRI vs UBLITUXIMAB-XIIY
TYSABRI vs UBROGEPANT